AI-generated summary
This scoping review and perspective describes transcranial photobiomodulation, which applies red and near-infrared light to the brain, across human studies for neurologic, psychiatric and other brain conditions. The authors report a biphasic dose-response, meaning both under- and overstimulation are possible, and suggest multiwavelength and pulsed approaches may improve outcomes. They describe the mechanisms as proposed rather than established.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a scoping review and perspective without reporting pooled outcomes, and it notes that preclinical studies were excluded from the human-focused review and that optimal protocols remain to be determined.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Neuromodulation, Attention-deficit/hyperactivity disorder, Reactive oxygen species, Traumatic brain injury, Neuroinflammation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.